Key Stats for SEM Stock
- Price Change for SEM stock: +8.4%
- $SEM Share Price as of March 03: $16
- 52-Week High: $19
- $SEM Stock Price Target: $17
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)>>>
What Happened?
Select Medical Holdings (SEM) stock jumped about 8.4% after news that the company agreed to be acquired by a consortium led by Robert A. Ortenzio, Martin F. Jackson, and private equity firm Welsh, Carson, Anderson & Stowe (WCAS). The group plans to acquire the healthcare operator for $16.50 per share, valuing the company at roughly $3.9 billion. The transaction was announced on March 3 and immediately drove strong trading activity.
The buyout offer represents a modest premium to recent trading levels and reflects investor interest in healthcare services businesses with stable patient demand. Reuters reported that lenders, including JPMorgan and Wells Fargo, committed about $1 billion in financing to support the acquisition. The financing package signals confidence that the deal will proceed through regulatory approvals.
Investors had already been watching the company closely, following strong fourth-quarter results released in February. Select Medical reported Q4 revenue of $1.40 billion, which beat analyst expectations of about $1.37 billion and grew roughly 6.4% year over year.
The company also declared a quarterly dividend of $0.0625 per share, payable in March to shareholders of record on March 2. Dividend announcements often support short-term investor sentiment because they signal stable cash flow generation. Combined with the buyout news, these updates helped push the stock higher this week.
See analysts’ growth forecasts and price targets for SEM stock (It’s free!) >>>
What the Market Is Telling Us About SEM Stock
The market reaction suggests investors see the buyout proposal as a credible path to exit for shareholders. Shares moved closer to the $16.50 offer price, which is typical when markets expect a deal to close. However, the stock still trades slightly below the bid, reflecting some uncertainty until the acquisition is finalized.
Healthcare services companies like Select Medical often attract private equity buyers because of predictable patient demand and reimbursement structures. The company operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics across the United States. These services are tied to long-term healthcare utilization trends.
Investors also appear to be weighing the company’s balance sheet. Select Medical carries roughly $2.8 billion in net debt, and its net debt to EBITDA ratio is about 3.7x. While leverage is manageable, the buyout could simplify the capital structure under private ownership.
If the deal closes as announced, public investors would receive the agreed purchase price in cash. However, the stock’s movement suggests markets are waiting for additional confirmation as the transaction moves through approvals.
Estimate a company’s fair value instantly (Free with TIKR) >>>
Should You Invest in Select Medical Holdings Corporation?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up SEM, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track SEM alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Analyze Select Medical Holdings stock on TIKR Free→
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
